Abstract 4007: Decipher the myth between progression-free survival and overall survival in HER-2 positive metastatic nreast cancer: Anti-HER2 antibody as the constant winner—A hypothesis-driven meta-regression analysis
Authors: I-Chun Chen, Fu-Chiang Hu, Ching-Hung Lin, Yen-Shen Lu
Published: 2019-08-07
DOI:
10.1158/1538-7445.am2019-4007
Source:
Full article
Abstract
Abstract